Recent advances in the treatment of hepatitis C in 2016
10.3760/cma.j.issn.1007-3418.2017.03.004
- VernacularTitle: 丙型肝炎研究领域2016年新进展
- Author:
Bifen LUO
1
;
Lai WEI
Author Information
1. Peking University People’s Hospital, Peking University Hepatology Institute, Beijing 100044, China
- Publication Type:Journal Article
- Keywords:
Hepatitis C, chronic;
Antiviral agents
- From:
Chinese Journal of Hepatology
2017;25(3):175-180
- CountryChina
- Language:Chinese
-
Abstract:
It has been rapidly developed in treatment of chronic hepatitis C from the past few years. Here we summarize the progress in chronic hepatitis C treatment in 2016. We introduce the pan-genotypic regimens with short-duration, the efficacy of DAA regimens in difficult-to-treat population, the influence on hepatocellular carcinoma, decompensation of liver cirrhosis, liver fibrosis and liver transplantation, the safety of DAA regimens in special population, information from real-world studies and data from China.
